What the HIPAA? Demystifying healthcare regulations for startups

Pfizer’s .5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing

Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing

Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the latest big pharma company to reach a deal that taps into Chinese labs

How Healthcare Organizations Can Benefit From an Agentic Artificial Intelligence Workshop

Earlier this year, during the HIMSS Global Health Conference and Exhibition in Las Vegas, healthcare IT leaders convened to share insights on the latest tools and processes

UnitedHealthcare removing prior approval for most pediatric services

Insurance giant UnitedHealthcare said it will drastically cut down its prior authorization requirements for pediatric care, as the company further scales back a process that

Pfizer, Innovent Ink Up-to-.5B+ Cancer Treatment Collaboration

Pfizer, Innovent Ink Up-to-$10.5B+ Cancer Treatment Collaboration

Pfizer and Innovent Biologics will partner to research and develop 12 early-stage and de novo antibodies and antibody-drug conjugates (ADCs) designed to treat various cancers, the companies

News and Analysis

Subscribe to newsletter

More Posts

Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing

How Healthcare Organizations Can Benefit From an Agentic Artificial Intelligence Workshop

UnitedHealthcare removing prior approval for most pediatric services

Pfizer, Innovent Ink Up-to-$10.5B+ Cancer Treatment Collaboration

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company